Financials
- Market Capitalization 315.88 M
- Employee 106
- Founded 2015
- CEO N/A
- Website www.foghorntx.com
- Headquarter Delaware, United States
- FIGI BBG00HFZPB88
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3230 | CTNM Contineum Therapeutics, Inc. - Common stock | 14.57 USD | -0.34% | -0.27% | +15.00% | -4.58% | 336.55 M USD | ||
| 3232 | PALI Palisade Bio, Inc. - Common Stock | 1.93 USD | +2.12% | -5.85% | +14.88% | +13.53% | 335.01 M USD | ||
| 3307 | LYEL Lyell Immunopharma, Inc. - Common Stock | 13.40 USD | -6.49% | -14.43% | +0.30% | -44.61% | 312.68 M USD | ||
| 3308 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 4.05 USD | +4.92% | +2.53% | +17.05% | +4.92% | 312.61 M USD |
Frequently asked questions about Foghorn Therapeutics Inc. - Common Stock
What is the Foghorn Therapeutics Inc. - Common Stock stock price today?
The current price of Foghorn Therapeutics Inc. - Common Stock (FHTX) is 5.38. Over the past 24 hours, the stock has changed by -1.10%. Follow the FHTX chart for real-time price dynamics.
What is the stock ticker of Foghorn Therapeutics Inc. - Common Stock?
Foghorn Therapeutics Inc. - Common Stock trades under the ticker FHTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Foghorn Therapeutics Inc. - Common Stock stock going up?
FHTX has changed by -8.97% over the last week, +30.58% over the last month, and +31.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Foghorn Therapeutics Inc. - Common Stock net income for the last quarter?
Foghorn Therapeutics Inc. - Common Stock reported net income of -19.88 M for the last quarter. The previous quarter showed -21.66 M, which means net income changed by +8.26%.
How many employees does Foghorn Therapeutics Inc. - Common Stock have?
As of the latest available data, Foghorn Therapeutics Inc. - Common Stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Foghorn Therapeutics Inc. - Common Stock EBITDA?
Foghorn Therapeutics Inc. - Common Stock EBITDA is -21.34 M, and its EBITDA margin is -653.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Foghorn Therapeutics Inc. - Common Stock stock?
You can buy Foghorn Therapeutics Inc. - Common Stock (FHTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Foghorn Therapeutics Inc. - Common Stock stock?
Investing in Foghorn Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FHTX chart and related analysis on metatrader.com as part of your research.